BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 26501741)

  • 1. Treatment and Outcome of Thrombolysis-Related Hemorrhage: A Multicenter Retrospective Study.
    Yaghi S; Boehme AK; Dibu J; Leon Guerrero CR; Ali S; Martin-Schild S; Sands KA; Noorian AR; Blum CA; Chaudhary S; Schwamm LH; Liebeskind DS; Marshall RS; Willey JZ
    JAMA Neurol; 2015 Dec; 72(12):1451-7. PubMed ID: 26501741
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Symptomatic intracranial hemorrhage following intravenous thrombolysis for acute ischemic stroke: a critical review of case definitions.
    Seet RC; Rabinstein AA
    Cerebrovasc Dis; 2012; 34(2):106-14. PubMed ID: 22868870
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Symptomatic intracerebral hemorrhage after intravenous thrombolysis in Chinese patients: comparison of prediction models.
    Li M; Wang-Qin RQ; Wang YL; Liu LB; Pan YS; Liao XL; Wang YJ; Xu AD
    J Stroke Cerebrovasc Dis; 2015 Jun; 24(6):1235-43. PubMed ID: 25891755
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravenous thrombolysis in young stroke patients: results from the SITS-ISTR.
    Toni D; Ahmed N; Anzini A; Lorenzano S; Brozman M; Kaste M; Mikulik R; Putaala J; Wahlgren N;
    Neurology; 2012 Mar; 78(12):880-7. PubMed ID: 22402853
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Results of intravenous thrombolysis within 4.5 to 6 hours and updated results within 3 to 4.5 hours of onset of acute ischemic stroke recorded in the Safe Implementation of Treatment in Stroke International Stroke Thrombolysis Register (SITS-ISTR): an observational study.
    Ahmed N; Kellert L; Lees KR; Mikulik R; Tatlisumak T; Toni D;
    JAMA Neurol; 2013 Jul; 70(7):837-44. PubMed ID: 23689267
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety of intravenous thrombolysis for acute ischemic stroke in patients receiving antiplatelet therapy at stroke onset.
    Diedler J; Ahmed N; Sykora M; Uyttenboogaart M; Overgaard K; Luijckx GJ; Soinne L; Ford GA; Lees KR; Wahlgren N; Ringleb P
    Stroke; 2010 Feb; 41(2):288-94. PubMed ID: 20056933
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of thrombolysis-associated symptomatic intracerebral hemorrhage.
    Goldstein JN; Marrero M; Masrur S; Pervez M; Barrocas AM; Abdullah A; Oleinik A; Rosand J; Smith EE; Dzik WH; Schwamm LH
    Arch Neurol; 2010 Aug; 67(8):965-9. PubMed ID: 20697046
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Stroke Registry Data on the Use of Intravenous Recombinant Tissue Plasminogen Activator in Stroke of Unknown Time of Onset.
    Balogun IO; Brown A; Bertoni M; Webb T; Hargroves D; Pullicino P
    J Stroke Cerebrovasc Dis; 2016 Aug; 25(8):1843-50. PubMed ID: 27132489
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pre-tissue plasminogen activator blood pressure levels and risk of symptomatic intracerebral hemorrhage.
    Tsivgoulis G; Frey JL; Flaster M; Sharma VK; Lao AY; Hoover SL; Liu W; Stamboulis E; Alexandrov AW; Malkoff MD; Alexandrov AV
    Stroke; 2009 Nov; 40(11):3631-4. PubMed ID: 19762689
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The THRIVE score predicts symptomatic intracerebral hemorrhage after intravenous tPA administration in SITS-MOST.
    Flint AC; Gupta R; Smith WS; Kamel H; Faigeles BS; Cullen SP; Rao VA; Bath PM; Wahlgren N; Ahmed N; Donnan GA;
    Int J Stroke; 2014 Aug; 9(6):705-10. PubMed ID: 25042855
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risks and Benefits Associated With Prestroke Antiplatelet Therapy Among Patients With Acute Ischemic Stroke Treated With Intravenous Tissue Plasminogen Activator.
    Xian Y; Federspiel JJ; Grau-Sepulveda M; Hernandez AF; Schwamm LH; Bhatt DL; Smith EE; Reeves MJ; Thomas L; Webb L; Bettger JP; Laskowitz DT; Fonarow GC; Peterson ED
    JAMA Neurol; 2016 Jan; 73(1):50-9. PubMed ID: 26551916
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Belgian experience with intravenous thrombolysis for acute ischemic stroke.
    Vanacker P; Thijs V; Peeters A; Bruneel B; Laloux P; Druwé P; De Deyn P; Ahmed N; Wahlgren N; Vanhooren G;
    Acta Neurol Belg; 2010 Jun; 110(2):157-62. PubMed ID: 20873445
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patient outcomes from symptomatic intracerebral hemorrhage after stroke thrombolysis.
    Strbian D; Sairanen T; Meretoja A; Pitkäniemi J; Putaala J; Salonen O; Silvennoinen H; Kaste M; Tatlisumak T;
    Neurology; 2011 Jul; 77(4):341-8. PubMed ID: 21715707
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Symptomatic intracerebral hemorrhage and recanalization after IV rt-PA: a multicenter study.
    Saqqur M; Tsivgoulis G; Molina CA; Demchuk AM; Siddiqui M; Alvarez-Sabín J; Uchino K; Calleja S; Alexandrov AV;
    Neurology; 2008 Oct; 71(17):1304-12. PubMed ID: 18753474
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predicting the risk of symptomatic intracerebral hemorrhage in ischemic stroke treated with intravenous alteplase: safe Implementation of Treatments in Stroke (SITS) symptomatic intracerebral hemorrhage risk score.
    Mazya M; Egido JA; Ford GA; Lees KR; Mikulik R; Toni D; Wahlgren N; Ahmed N;
    Stroke; 2012 Jun; 43(6):1524-31. PubMed ID: 22442178
    [TBL] [Abstract][Full Text] [Related]  

  • 16. STARTING-SICH Nomogram to Predict Symptomatic Intracerebral Hemorrhage After Intravenous Thrombolysis for Stroke.
    Cappellari M; Turcato G; Forlivesi S; Zivelonghi C; Bovi P; Bonetti B; Toni D
    Stroke; 2018 Feb; 49(2):397-404. PubMed ID: 29311264
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk factors for severe hemorrhagic transformation in ischemic stroke patients treated with recombinant tissue plasminogen activator: a secondary analysis of the European-Australasian Acute Stroke Study (ECASS II).
    Larrue V; von Kummer R R; Müller A; Bluhmki E
    Stroke; 2001 Feb; 32(2):438-41. PubMed ID: 11157179
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predicting risk of symptomatic intracerebral hemorrhage and mortality after treatment with recombinant tissue-plasminogen activator using SEDAN score.
    Al-Khaled M; Langner B; Brüning T
    Acta Neurol Scand; 2016 Apr; 133(4):239-44. PubMed ID: 26033162
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Four-Year Experience of Symptomatic Intracranial Hemorrhage Following Intravenous Tissue Plasminogen Activator at a Comprehensive Stroke Center.
    Orlando A; Wagner JC; Fanale CV; Whaley M; McCarthy KL; Bar-Or D
    J Stroke Cerebrovasc Dis; 2016 Apr; 25(4):969-76. PubMed ID: 26856464
    [TBL] [Abstract][Full Text] [Related]  

  • 20. External validation of the SEDAN score for prediction of intracerebral hemorrhage in stroke thrombolysis.
    Mazya MV; Bovi P; Castillo J; Jatuzis D; Kobayashi A; Wahlgren N; Ahmed N
    Stroke; 2013 Jun; 44(6):1595-600. PubMed ID: 23632975
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.